IBM reports Q2 revenues of $20B, vs. $19.85B expected, up 4% YoY, marking IBM's third consecutive quarter of revenue growth after five years of YoY declines
Jordan Novet / CNBC :
Context & Ripple Effects
This closes the arc opened in April, when IBM's $19.1B Q1 beat delivered its second consecutive growth quarter after a five-year drought of year-over-year declines; a $20B Q2, up 4% and ahead of the $19.85B consensus, makes it three.
The significance is less the size of the beat than what it licenses. The later record shows IBM converting the turnaround into an acquisition-and-software strategy: Red Hat powered the next growth inflection in early 2020, and by late 2022 software was carrying the beats outright.
First-order effects
- Investors get confirmation the recovery is real rather than a one-quarter fluke, shifting the debate from whether IBM can grow at all to how durable and how profitable the growth is.
Second-order effects
- A credible growth streak resets the performance bar for management — expectations move from revenue stabilization to segment-level expansion, raising the penalty for any future miss, a dynamic visible when IBM fell 5%+ on a soft Q1 2024 print despite positive software growth.
Third-order effects
- If the pattern holds, the structural answer to the five-year decline is a portfolio rebuilt around software and acquired recurring revenue — the trajectory the Q3 2022 beat and the 2023–2024 results trace out.
The trend: Legacy enterprise IT vendors are restarting growth through software portfolios and acquisitions rather than waiting for their traditional hardware and services businesses to recover.